Welcome to The FamilieSCN2A Foundation
The global leader in SCN2A-related autism & epilepsy research, advocacy, and community. Discover the difference families make.
Families Connected
0
Granted Research
$
0
M
Papers Published
0
Countries
0
Conferences Hosted
0
Here you will find the world’s largest SCN2A community and the most complete body of research and information on SCN2A-Related Disorders (SRDs).
Most rare diseases do not have a cure. However, recent progress in precision medicine, drug repurposing, and gene therapy are offering hope for treating these types of disorders. Our mission is to accelerate this work.
What are SCN2A-Related Disorders (SRDs)?
SCN2A is the name of a gene that is commonly associated with early-onset epilepsy and is a leading monogenetic cause of autism spectrum disorder.
EL-PFDD Meeting
We are pleased to announce the FamilieSCN2A Foundation will host an Externally-led Patient-Focused Drug Development (EL-PFDD) meeting on Friday, October 23, 2026. The goal of this public meeting is to share the critical patient voice for future drug development efforts and key stakeholders, including the US Food and Drug Administration (FDA).
Stay in Touch
Join our email list to stay informed about the latest research, clinical trials, community events, advocacy efforts, and all things SCN2A-related.
Community
A decade ago an SCN2A diagnosis meant accepting that you were alone and that no one was even studying it. Today, SRDs are at the forefront of scientific research and supported by a global community.
Newly Diagnosed?
You are not alone. Here you will find a caring community and abundant resources on SCN2A-related disorders (SRDs). Whether you have a newborn baby with epilepsy or are an adult with autism, we welcome ALL those with SRDs. We are glad you found us.